Division of Adolescent and Young Adult Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Population Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
J Adolesc Health. 2023 Jul;73(1):198-200. doi: 10.1016/j.jadohealth.2023.01.021. Epub 2023 Apr 3.
Despite advancements in developing a vaccine for Chlamydia trachomatis (CT), vaccine hesitancy has historically limited the adoption of sexually transmitted infection immunization. This report investigates adolescent perspectives toward a potential CT vaccine and vaccine research.
As part of the Technology Enhanced Community Health Nursing (TECH-N) study, conducted from 2012-2017, we surveyed 112 adolescents and young adults aged 13-25 years who presented with pelvic inflammatory disease regarding their perspectives on a CT vaccine and willingness to participate in vaccine research. Descriptive statistical analyses were conducted.
Most participants were African American (95%), on Medicaid (89%), and sexually experienced (100%). Most respondents would accept a vaccine (95%) and preferred a provider's recommendation (86%) over parents, partners, or friends. A majority (70%) would not be embarrassed to participate in research.
Respondents showed favorable attitudes toward CT vaccination and research in this high-risk study population.
尽管在开发衣原体(CT)疫苗方面取得了进展,但疫苗犹豫一直以来都限制了性传播感染免疫接种的采用。本报告调查了青少年对潜在 CT 疫苗和疫苗研究的看法。
作为 TECHNOLOGY-ENHANCED COMMUNITY HEALTH NURSING(TECH-N)研究的一部分,该研究于 2012-2017 年进行,我们调查了 112 名年龄在 13-25 岁之间因盆腔炎就诊的青少年和年轻人,了解他们对 CT 疫苗的看法以及对疫苗研究的参与意愿。进行了描述性统计分析。
大多数参与者是非洲裔美国人(95%),享受医疗补助(89%),有过性经历(100%)。大多数受访者会接受疫苗(95%),并更喜欢医生的推荐(86%),而不是父母、伴侣或朋友的推荐。大多数(70%)人不会因为参与研究而感到尴尬。
在这一高风险的研究人群中,受访者对 CT 疫苗接种和研究表现出了有利的态度。